Kaos Capital Acquires 4.9% Stake in BioRestorative Therapies
May 27, 2026
Kaos Capital Ltd. acquired a 4.9% stake in BioRestorative Therapies, Inc. (NASDAQ: BRTX) through open-market purchases. The hedge fund says BRTX should consider a comprehensive strategic review and potentially pivot into broader AI opportunities, and it plans to seek an immediate meeting with the board to discuss strategy and governance.
- Buyers
- Kaos Capital Ltd.
- Targets
- BioRestorative Therapies, Inc.
- Industry
- AI & Machine Learning
- Location
- United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.